Polyphron
An AI-guided tissue-engineering platform that grows human micro-tissues and models their responses to support drug research and development.
$20MSeed
LeadQC
Quiet Capital
Activity from announced rounds
Activity in this selectionBiotech
Quiet Capital is the venture firm named by RWX and Thatch in their financing announcements.
Recorded funding activity
RWX supplies cloud environments for testing agent-developed software. Thatch manages employee-directed health benefits, while Polyphron develops micro-tissue models for drug research. The company histories preserve these distinct applications.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- 1 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $350M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionScience Corporation
Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases
$230MSeries C
Role not disclosedLoyal
Loyal develops medicines intended to extend dogs’ lifespans.
$100MSeries C
Role not disclosed